FYARRO vs RAPAMUNE
Independent side-by-side comparison.
Rating
New
New
Pharmacy pays
~$48.61 /30
~$48.61 /30
Type
RX
RX
Active ingredient
SIROLIMUS
SIROLIMUS
Manufacturer
Dosage forms
Injectable
Solution
Drug class
Kinase Inhibitor
Kinase Inhibitor
Boxed warning
None
Treats
Lymphangioleiomyomatosis, Perivascular Epithelioid Cell Neoplasms
Lymphangioleiomyomatosis, Perivascular Epithelioid Cell Neoplasms
Frequently asked questions
Which is cheaper, Fyarro or Rapamune?
Pharmacies pay about the same to acquire either one — roughly $48.61 for a 30-count supply, per the CMS NADAC survey. That is not what you will be charged: your price is set by your insurer and the pharmacy, not by what the drug cost them.
What is the difference between Fyarro and Rapamune?
Both Fyarro and Rapamune share the active ingredient Sirolimus.
Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.